Target intelligence / Profile preview

Solute carrier organic anion transporter family member 5A1 (SLCO5A1)

Target
SLCO5A1
Molecular classification
Transporter, Solute carrier (SLC) superfamily, Organic anion transporting polypeptide (OATP) family
01

Overview

Solute carrier organic anion transporter family member 5A1 (SLCO5A1) is a human membrane protein with 12 transmembrane domains, part of the organic anion transporting polypeptide (OATP) family within the solute carrier (SLC) superfamily[1][3]. It is encoded by the SLCO5A1 gene on chromosome 8 and consists of 848 amino acids[1][3]. SLCO5A1 is expressed in various normal and cancerous tissues, including the brain, heart, skeletal muscle, ovary, and different types of cancer such as breast, prostate, and liver[1][3]. It is most notably found on the plasma membrane of epithelial cells and is upregulated during dendritic cell maturation, suggesting a role in immune cell differentiation[1][3]. Some data link this transporter to hormone uptake in breast cancer and drug resistance in small cell lung cancer, possibly by mediating intracellular drug sequestration rather than direct cellular uptake[3][1]. While its detailed substrate specificity remains under-characterized, SLCO5A1 likely participates in the transport of amphipathic organic anions and may modulate hormone or drug disposition in tissues[5][3]. The transporter is also implicated in developmental disorders such as Mesomelia-synostoses syndrome, potentially through gene haploinsufficiency[1]. SLCO5A1 is considered a non-classical OATP member and is under study for its role in cell shape reorganization, migration, and proliferation, especially in the immune and cancer context[3][1].

Other names
Organic anion transporter polypeptide-related protein 4OATP5A1SLC21A15OATP-RP4OATP-JOATPJOATPRP4Solute carrier family 21 member 15
02

Biological functions

Organic anion transportCellular differentiation (especially antigen presenting cells)Cell migrationPotentially cell proliferation regulation
03

Disease associations

Cancer (breast cancer, prostate cancer, small cell lung cancer, hepatic tumor, bone tumors)Chemotherapy resistance (particularly drug sequestration)Potential involvement in developmental syndromes (e.g., Mesomelia-synostoses syndrome)Other (possible roles in pregnancy establishment and maintenance by prostaglandin transport)
04

Safety considerations

Inter-individual variation in drug response due to transporter expression or genetic variantPotential influence on chemotherapy resistance in cancer via transporter-mediated sequestration

Beyond the preview

Go deeper on Solute carrier organic anion transporter family member 5A1 (SLCO5A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier organic anion transporter family member 5A1 (SLCO5A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call